GE HealthCare increases quarterly dividend 17% and sets medium-term targets at 2024 Investor Day

GE HealthCare Technologies Inc.

Quarterly cash dividend increased ~17%; no new per-share amount or dates stated in release.
Medium-term (2026-2028) targets: organic revenue growth 4-6%, adjusted EBIT margin high-teens to 20%+, adjusted EPS growth high-single to low-double digit, FCF conversion 90%+.
Reiterated 2024 outlook: organic revenue growth 1-2% trending lower end, adjusted EBIT margin 15.8-16.0%, adjusted EPS $4.25-$4.35, FCF ~$1.8B.
Company highlighted progress since spin-off and precision care strategy focused on AI, radiopharmaceuticals, and enterprise partnerships.
CEO Peter Arduini expressed confidence in growth pipeline; CFO Jay Saccaro cited margin expansion and disciplined capital allocation.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.